Efficacy and Safety of Lodenafil Carbonate in the Treatment of Erectile Dysfunction in Patients With Diabetes.
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Sixty diabetes men with erectile dysfunction from mild to severe who agree to participate is
going to have medical care approximately for 16 weeks.
During the first 4 weeks, patients will not receive any inhibitor of phosphodiesterase 5. In
the following eight weeks, patients will receive oral lodenafil carbonate. They will complete
the International Index of Erectile Dysfunction (IIEF) questionnaire in the site and answer
the Sexual Encounter Profile (SEP) questions 2 and 3 and the Erection Hadness Score (EHS)
after each intercourse or attempt without or using oral lodenafil cardonate 80mg.
Questionnaire of adverse event is included in patient diary.